Skip to main content
Premium Trial:

Request an Annual Quote

TurboGenomics Partners with Entropia to Deliver Distributed Sequence Comparison Software

NEW YORK, July 10 - TurboGenomics and Entropia will collaborate to deliver high-performance sequence comparison analysis on large enterprise networks, the companies said Tuesday.

Entropia, of San Diego, will combine its PC-based distributed computer platform with New Haven-based TurboGenomics' TurboBLAST sequence comparison tool. The companies anticipate the product will be available by the third quarter of 2001.

"Working with Entropia opens the doors to using TurboBLAST in even more computing environments, particularly in large enterprise networks," Gregory Gardiner, CEO of TurboGenomics, said in a statement. "The Entropia platform's scalability, careful management of CPU and disk usage, and security features are all tailored specifically for the corporate enterprise environment."

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.